Funded Tech Companies

ImpriMed

Operating out of Palo Alto, ImpriMed has funding from LB Investment, Samsung Securities and Han River Partners.

Company Overview

Contact Information

Company Background Information

Overview

ImpriMed develops a personalized drug testing service to look into drug responses of pet patient's live cancer cells before treatment. The company helps veterinary oncologists decide a final treatment regimen based on data-driven prediction of response success in each individual patient body and builds up a patient-derived database.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

9/21/2026

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Sungwon Lim

        

Co-Founder

Mainak Chowdhury

        

Co-Founder

Jamin Koo

        

Co-Founder

David Kurtz

        

Co-Founder

Hye Lee

        

VP - Operations

Mary Ocnean

        

Company Investors

• LB Investment
• Samsung Securities
• Han River Partners
• NAVER D2 Startup Factory
• BonAngels Venture Partners
• SK Telecom Ventures
• Murex Partners
• Ignite Innovation Fund
• Samyang Chemical Group
• SoftBank Ventures Korea
• KDB Industrial Bank
• Byucksan
• HG Initiative
• FuturePlay
• Murex Investments
• Draper Associates
• Translink Capital
• ES Investor
• DraperDragon
• Primer Sazze Partners
• StartX
• Plug and Play Ventures

Browse more funded tech companies:

Impress Software | Imprint

Share this article

About Our VC & M&A Database

The company data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary